Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA Mounjaro pack is a pre-filled KwikPen containing four doses of tirzepatide, giving you one month of once-weekly injections. Each pen is manufactured by Eli Lilly and comes in one of six UK strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg. Which strength you receive (and how many pens come in any given bundle) is a clinical decision, not a shopping one. Mounjaro is a Prescription-Only Medicine, so a prescriber must assess your health before any pack is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Open any Mounjaro pack and you'll find one KwikPen, a package of needles, and the Patient Information Leaflet. The pen is pre-filled and pre-set; there's nothing to mix or measure. Four clicks of the plunger, one per week for four weeks. Simple in practice.
What varies is the strength printed on the label. Tirzepatide works as a dual GIP and GLP-1 receptor agonist, the only weight-loss medicine in the UK that activates both pathways simultaneously. The clinical programme showed average body-weight reductions of around 20–21% at the highest dose over 72 weeks, but that result is reached through a gradual titration schedule, not from the first pen. The full Mounjaro overview covers the mechanism in more detail if you want the science. For now, the practical point is this: a 2.5 mg pack and a 15 mg pack look almost identical, but they are not interchangeable, and your prescriber decides which one is right for you at each stage.
The NHS medicines page for tirzepatide lists the available strengths and explains the titration logic for anyone who wants an independent UK source to cross-reference.
The terminology around multi-pen packs can be confusing, so here is what each one tends to mean in practice. A Mounjaro starter pack typically covers the first month or two of treatment at the lower doses, structured around the initial titration steps. A bundle pack groups two or more pens, usually across sequential strengths, to match a prescribed escalation plan. A three-month starter pack is designed to take a new patient through the early phase of treatment without repeated orders during a settling-in period.
None of these formats overrides clinical review. At a regulated pharmacy, each multi-pen order is assessed before dispensing, the bundle structure follows the prescriber's plan, not the other way around. If you are transferring from another provider or requesting a dose increase, evidence of your current treatment is reviewed first. That is not bureaucracy; it is the safeguard that makes multi-pen prescribing safe.
For context on how pricing varies across pack types and what a legitimate private prescription should include, the Mounjaro package page covers the cost considerations worth understanding before you commit to any format.
This is worth thirty seconds of your time. Every legitimate Mounjaro KwikPen arrives in Eli Lilly's original manufacturer packaging, with a batch number, expiry date, and a Patient Information Leaflet printed in English. The pen itself has a clear window showing the liquid inside; it should be colourless and free of particles. If anything looks different (mismatched fonts, unusual seals, missing leaflet) stop and report it to the MHRA via the Yellow Card scheme. Counterfeits are not a fringe concern. The MHRA seized around 20 million doses of illegally traded weight-loss medicines worth roughly £45 million in 2025 alone, and fake pens have been found to contain insulin, a genuinely dangerous substitution.
The single most effective check is confirming that the pharmacy dispensing your pack is registered with the GPhC. You can verify any online pharmacy at the GPhC pharmacy register in under a minute. Look for the registration number and confirm it matches. Sellers offering packs without requiring a valid prescription are operating outside the law, and outside the supply chain that makes genuine pens traceable.
A gap between packs is not simply an inconvenience. Tirzepatide's effects on appetite and gastric emptying diminish once dosing stops, and restarting after a significant break may mean returning to a lower dose to avoid side effects that had settled during earlier titration. The effects of stopping Mounjaro page covers what the evidence says about weight regain and restarting in more detail.
If your next pack will be a different strength from your last (whether stepping up or stepping down) that change requires prescriber sign-off. At nume, every repeat order is clinically re-reviewed; there are no automatic renewals. A three-pack bundle can be useful for patients on a stable dose who want fewer ordering cycles, but the clinical assessment still happens before each dispatch. That is the model; if you'd like to talk through what suits your situation, checking your eligibility with our prescribers is the right first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.